STAT3 and esophageal squamous cell carcinoma: Therefore, inhibiting the expression of AGK or using competitive AGK peptide to inhibit AGK-JAK interaction can be used as a novel and valuable method to block the activation of JAK/STAT3 in some tumors, such as ESCC (Chen et al., 2013).